# The Contact PVI Study: Use of Tissue Contact Data to Guide Atrial Fibrillation Ablation

Study · id `cardio:ct-nct01629056` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01629056](<https://clinicaltrials.gov/study/NCT01629056>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01629056

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 148 participants.

## Technical summary

Registry record NCT01629056. Randomized; single masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2013-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 148 participants (enrolled count; ClinicalTrials.gov record NCT01629056, source copy `cardio:ctgov-nct01629056-2017-10-13`, retrieved 2026-10-26)
- Start date: 2012-01 (registry gives no type) (ClinicalTrials.gov record NCT01629056, source copy `cardio:ctgov-nct01629056-2017-10-13`, retrieved 2026-10-26)
- Primary completion: 2013-12 (actual) (ClinicalTrials.gov record NCT01629056, source copy `cardio:ctgov-nct01629056-2017-10-13`, retrieved 2026-10-26)
- Completion: 2014-02-03 (actual) (ClinicalTrials.gov record NCT01629056, source copy `cardio:ctgov-nct01629056-2017-10-13`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT01629056, source copy `cardio:ctgov-nct01629056-2017-10-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01629056-2017-10-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Contact PVI Study: Use of Tissue Contact Data to Guide Atrial Fibrillation Ablation
- Condition: Atrial Fibrillation
- Intervention (Procedure): ablation
- Intervention (Procedure): RF ablation
- Lead sponsor: Oxford University Hospitals NHS Trust
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Oxford University Hospitals NHS Trust (`cardio:org-oxford-university-hospitals-nhs-trust`)

## Provenance

Content hash: d4f57c5ac9e63afea0add97d6da2f475c5abef70a92914ec2d099266305e7a2f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
